Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gelok International is a U.S.-based manufacturer of superabsorbent laminates, composites, and airlaid materials used in medical, hygiene, industrial, and packaging applications. The company develops low-profile absorbent materials designed to capture and lock aqueous fluids such as blood, exudate, and urine, with products positioned for wound care, incontinence products, medical packaging, cleanup, and filtration uses. Its main branded offerings include Gelok laminates and TotalCore airlaids, which are customizable and available with different substrate, cellulose, and superabsorbent polymer configurations. Gelok operates as a division of Principle Business Enterprises and appears to be a commercially active operating business rather than a therapeutic drug developer. For a biotech or healthcare analyst, Gelok is best understood as a specialty medical-materials and absorbent-technology company serving healthcare-adjacent and medical device supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gelok International.